Gigaxonin E3 ligase governs ATG16L1 turnover to control autophagosome production.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
15 02 2019
Historique:
received: 19 08 2016
accepted: 21 12 2018
entrez: 17 2 2019
pubmed: 17 2 2019
medline: 9 4 2019
Statut: epublish

Résumé

Autophagy is an essential self-digestion machinery for cell survival and homoeostasis. Membrane elongation is fundamental, as it drives the formation of the double-membrane vesicles that engulf cytosolic material. LC3-lipidation, the signature of autophagosome formation, results from a complex ubiquitin-conjugating cascade orchestrated by the ATG16L1 protein, whose regulation is unknown. Here, we identify the Gigaxonin-E3 ligase as the first regulator of ATG16L1 turn-over and autophagosome production. Gigaxonin interacts with the WD40 domain of ATG16L1 to drive its ubiquitination and subsequent degradation. Gigaxonin depletion induces the formation of ATG16L1 aggregates and impairs LC3 lipidation, hence altering lysosomal fusion and degradation of the main autophagy receptor p62. Altogether, we demonstrate that the Gigaxonin-E3 ligase controls the production of autophagosomes by a reversible, ubiquitin-dependent process selective for ATG16L1. Our findings unveil the fundamental mechanisms of the control of autophagosome formation, and provide a molecular switch to fine-tune the activation of autophagy.

Identifiants

pubmed: 30770803
doi: 10.1038/s41467-019-08331-w
pii: 10.1038/s41467-019-08331-w
pmc: PMC6377711
doi:

Substances chimiques

ATG16L1 protein, human 0
Autophagy-Related Proteins 0
Cytoskeletal Proteins 0
GAN protein, human 0
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

780

Commentaires et corrections

Type : CommentIn

Références

Nature. 2008 Nov 13;456(7219):259-63
pubmed: 18849966
Dev Cell. 2014 Jul 14;30(1):71-85
pubmed: 25026034
J Exp Med. 2017 Feb;214(2):423-437
pubmed: 28082356
Hum Mol Genet. 2003 Apr 15;12(8):813-22
pubmed: 12668605
Cell Biochem Biophys. 2013 Sep;67(1):3-13
pubmed: 23709310
J Cell Biol. 2012 Feb 20;196(4):407-17
pubmed: 22331844
Nat Genet. 2000 Nov;26(3):370-4
pubmed: 11062483
EMBO Rep. 2013 Feb;14(2):206-11
pubmed: 23238393
J Cell Sci. 2012 May 15;125(Pt 10):2343-8
pubmed: 22736434
Mol Cell. 2014 Jan 23;53(2):167-78
pubmed: 24462201
Nature. 2008 Nov 13;456(7219):264-8
pubmed: 18849965
Nat Cell Biol. 2003 Nov;5(11):1001-7
pubmed: 14528312
J Clin Invest. 2013 May;123(5):1964-75
pubmed: 23585478
J Cell Sci. 2015 Apr 1;128(7):1259-67
pubmed: 25829512
EMBO J. 2012 Nov 14;31(22):4304-17
pubmed: 23064152
J Neurosci. 2016 Jun 1;36(22):5933-45
pubmed: 27251616
Autophagy. 2015;11(1):28-45
pubmed: 25484070
Nat Genet. 2013 Apr;45(4):445-9, 449e1
pubmed: 23435086
Annu Rev Cell Dev Biol. 2011;27:107-32
pubmed: 21801009
Science. 2000 Dec 1;290(5497):1717-21
pubmed: 11099404
Mol Cell. 2014 Jul 17;55(2):238-52
pubmed: 24954904
Hum Mol Genet. 2009 Apr 15;18(8):1384-94
pubmed: 19168853
Mol Neurodegener. 2011 Apr 12;6:25
pubmed: 21486449
Nature. 2010 Jul 1;466(7302):68-76
pubmed: 20562859
Am J Physiol Cell Physiol. 2016 Sep 1;311(3):C351-62
pubmed: 27335173
Cell Div. 2016 Jun 10;11:8
pubmed: 27293474
J Cell Biol. 1993 Apr;121(2):305-15
pubmed: 7682217
J Biol Chem. 2007 Mar 2;282(9):6763-72
pubmed: 17192262
Nature. 2008 Feb 28;451(7182):1069-75
pubmed: 18305538
Nat Cell Biol. 2010 Sep;12(9):823-30
pubmed: 20811354
FEBS Lett. 2013 Jun 27;587(13):1988-96
pubmed: 23669359
Autophagy. 2010 May;6(4):506-22
pubmed: 20505359
Nat Struct Mol Biol. 2014 Apr;21(4):336-45
pubmed: 24699082
Trends Biochem Sci. 2013 Sep;38(9):453-60
pubmed: 23870665
Nature. 2014 Feb 27;506(7489):456-62
pubmed: 24553140
EMBO J. 1999 Jul 15;18(14):3888-96
pubmed: 10406794
Autophagy. 2014 Mar;10(3):522-3
pubmed: 24413923
Brain Res. 2016 Oct 15;1649(Pt B):143-150
pubmed: 27038755
Autophagy. 2007 Mar-Apr;3(2):139-41
pubmed: 17204855
EMBO J. 2001 Nov 1;20(21):5971-81
pubmed: 11689437
Mol Biol Cell. 2008 May;19(5):2092-100
pubmed: 18321988
Nat Cell Biol. 2013 Jul;15(7):713-20
pubmed: 23817233
J Cell Sci. 2003 May 1;116(Pt 9):1679-88
pubmed: 12665549
J Cell Biol. 2013 Oct 14;203(1):115-28
pubmed: 24100292
Nat Rev Neurosci. 2015 Jun;16(6):345-57
pubmed: 25991442
Autophagy. 2015;11(1):190-1
pubmed: 25629784
Curr Opin Genet Dev. 2014 Jun;26:16-23
pubmed: 24907664

Auteurs

Aurora Scrivo (A)

Avenir-Atip team, INM, INSERM, Université Montpellier, 34091, Montpellier, France.
Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, 10461, New York, NY, USA.

Patrice Codogno (P)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR8253, 75993, Paris, France.
Université Paris Descartes-Sorbonne Paris Cité, 75006, Paris, France.

Pascale Bomont (P)

Avenir-Atip team, INM, INSERM, Université Montpellier, 34091, Montpellier, France. pascale.bomont@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH